Variable | CN (n = 28) | MCI– (n = 27) | MCI+ (n = 36) | AD (n = 24) | p value |
---|---|---|---|---|---|
AV45 SUVR | 1.16 (0.21) | 1.01 (0.05) | 1.39 (0.17) | 1.50 (0.15) | < 0.001 |
Age (years) | 74 (5.71) | 71.36 (8.03) | 72.58 (5.79) | 74 (7.32) | 0.42 |
Education (years) | 16.43 (1.93) | 16.48 (2.68) | 15.86 (2.46) | 15.46 (2.50) | 0.36 |
Females | 15 (54%) | 12 (44%) | 14 (39%) | 12 (50%) | 0.67 |
ICV (mm3) | 1,572,034 (153,316.20) | 1,545,103 (168,923.10) | 1,568,839 (174,101.60) | 1,574,218 (210,862) | 0.94 |
APOE ε4 | 10 (36%) | 4 (15%) | 24 (66%) | 20 (83%) | < 0.001a |
ADNI-Mem | 0.89 (0.52) | 0.37 (0.49) | 0.15 (0.60) | −1.10 (0.56) | < 0.001 |
ADNI-EF | 0.80 (0.56) | 0.25 (0.80) | 0.34 (0.86) | −0.94 (0.62) | < 0.001 |
CDR-SB | 0.05 (0.16) | 1.26 (0.92) | 1.90 (1.06) | 4.41 (1.31) | < 0.001 |
FC DMN-DAN | −0.12 (0.28) | 0.00 (0.33) | −0.03 (0.24) | −0.15 (0.30) | 0.17 |
FC DMN-SN | −0.15 (0.29) | −0.11 (0.28) | −0.08 (0.28) | −0.18 (0.27) | 0.56 |
FC DMN-FPN | 0.31 (0.23) | 0.20 (0.30) | 0.26 (0.23) | 0.17 (0.29) | 0.24 |
Follow-up time (years) | 1.63 (1.24) | 1.30 (0.96) | 1.46 (1.09) | 0.90 (0.53) | 0.001 |